Collateral for a security interest recorded Sep 14, 2022 (Vickers Venture Fund VI Pte. Ltd.).
Lapsed Oct 23, 2026 on the fee record · Low confidence
20-year base term ends Dec 15, 2030
Second maintenance fee unpaid; grace period ended. The USPTO has not yet posted the lapse.
Held by Biosplice Therapeutics, Inc.
Filed Nov 14, 2017 as application 15/812,629 · Granted Oct 23, 2018
Base term, 20 years from filing
Today
Lapsed Oct 23, 2026
2010
2030
Clock starts
Dec 15, 2010
Dec 15, 2010
No longer in force
Oct 23, 2026
Oct 23, 2026
Granted
Oct 23, 2018
Oct 23, 2018
Term would have run to
Dec 15, 2030
Dec 15, 2030
base term
after the term ends
fee events
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
1 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
8
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.
Its term would have run to Dec 15, 2030: its 20-year base term, with no adjustment for prosecution delay. Confidence: Low. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Dec 15, 2010, when application 12/968,505, the earliest non-provisional in its chain, was filed (this one was filed Nov 14, 2017) | Dec 15, 2030 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | No fee event states this; the fee state is read from the payments the fee record holds; the fee record shows no payment for this window, and USPTO's status still reads "Patented Case" | lapsed Oct 23, 2026 | Low confidence |
| Computed term end | The steps above, in order | Oct 23, 2026 | Low confidence |
This family
| US 8,450,340 | In force Sep 2031 | Sep 2031 |
| US 8,815,897 | Lapsed on the fee record Aug 2026 | Aug 2026 |
| US 8,846,714 | Lapsed on the fee record Sep 2026 | Sep 2026 |
| US 8,901,150 | In force Dec 2030 | Dec 2030 |
| US 9,067,939 | In force Dec 2030 | Dec 2030 |
| US 9,446,035 | In force Dec 2030 | Dec 2030 |
| US 9,855,272 | Lapsed on the fee record Jan 2026 | Jan 2026 |
| US 10,105,370 | this patent Oct 2026 | Oct 2026 |
Every application listed has its file history here. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jun 22, 2018 Reel 46182, frame 79 | Hood, John; Kc, Sunil Kumar; Wallace, David Mark | Epitherix, LLC | Assignment of Assignor's Interest |
| Jun 22, 2018 Reel 46182, frame 238 | Epitherix, LLC | Samumed, LLC | Assignment of Assignor's Interest |
| Mar 23, 2021 Reel 55693, frame 809 | Samumed, LLC | Biosplice Therapeutics, Inc. | Assignment of Assignor's Interest |
| Sep 14, 2022 Reel 61433, frame 786 | Biosplice Therapeutics, Inc. | Vickers Venture Fund VI Pte. Ltd.; Vickers Venture Fund VI (Plan) Pte. Ltd.; Vickers-Splice Co.-Investment LLC; Med-Pathways II Limited | Security Interest |
| Sep 14, 2022 reel/frame not recorded | Biosplice Therapeutics, Inc. | Vickers Venture Fund VI Pte. Ltd. | Security Interest |
| Sep 14, 2022 reel/frame not recorded | Biosplice Therapeutics, Inc. | Vickers Venture Fund VI (Plan) Pte. Ltd. | Security Interest |
| Sep 14, 2022 reel/frame not recorded | Biosplice Therapeutics, Inc. | Vickers-Splice Co.-Investment LLC | Security Interest |
| Sep 14, 2022 reel/frame not recorded | Biosplice Therapeutics, Inc. | Med-Pathways II Limited | Security Interest |
| Mar 12, 2026 Reel 75109, frame 434 | TMF Group New York, LLC, Not Individually But Solely as Collateral Agent | Biosplice Therapeutics, Inc. | Release of Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
Citations
32
later US patents cite this one
That is top 10% of utility patents granted in 2018 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.